EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Downregulation of TNFAIP3 Associated With Poor Prognosis and Immune Response in Breast Cancer

Yeqin Wu, Zhaoyang Qin, Gangping Wang

Cancer Reports · 2026

DOI: 10.1002/cnr2.70443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2026. Verfasst von Yeqin Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Fourth Affiliated Hospital of School of Medicine, & International School of Medicine, International Institutes of Medici…. Hauptthemen laut MEDLINE: Breast Neoplasms, Tumor Necrosis Factor alpha-Induced Protein 3, Biomarkers, Tumor. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer (BRCA) progression is closely linked to dysregulated inflammatory processes within the tumor microenvironment (TME). TNFAIP3, a key regulator of TNF‐α signaling, plays a dual role in cancer biology, but its precise function in BRCA pathogenesis and immune modulation remains unclear.

Aims

This study aimed to elucidate the clinical significance, immune regulatory role, and molecular mechanisms of TNFAIP3 in BRCA progression. Methods and Results We conducted an analysis of RNA‐seq data from 1113 BRCA samples and 113 normal samples sourced from TCGA, along with protein data from 125 BRCA samples and 18 normal samples obtained from the CPTAC database. Comprehensive analyses included: (1) differential expression across cancer types and BRCA subtypes; (2) correlation with clinicopathological features; (3) survival analysis using Kaplan–Meier and Cox regression; (4) immune cell infiltration assessment via ssGSEA; and (5) co‐expression analysis of TNFAIP3‐LINC01096. TNFAIP3 was significantly downregulated in BRCA ( p < 0.001) and associated with aggressive features, including advanced TNM stage (T4 vs. T1, p = 0.021) and poor prognosis (HR = 1.48, p = 0.035). Immune profiling revealed strong correlations with cytotoxic T cells ( ρ = 0.632) and dendritic cells ( ρ = 0.602). A novel TNFAIP3‐LINC01096 regulatory network was identified ( ρ = 0.582, p < 0.001), potentially mediated by shared miR‐3130‐3p binding sites.

Conclusion

Our findings suggest a role of TNFAIP3 as a critical regulator of BRCA progression and tumor immunity. The TNFAIP3‐LINC01096 axis represents a promising therapeutic target, particularly for immunotherapy‐resistant cases. These results provide a rationale for developing TNFAIP3‐based prognostic tools and immunomodulatory strategies in BRCA management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsTumor Necrosis Factor alpha-Induced Protein 3Biomarkers, TumorHumansFemalePrognosisTumor MicroenvironmentGene Expression Regulation, NeoplasticDown-RegulationMiddle AgedKaplan-Meier Estimate

Stichwörter der Autor:innen

LINC01096TNFAIP3breast cancer (BRCA)immune infiltrationprognostic biomarkertumor microenvironment

Substanzen

Tumor Necrosis Factor alpha-Induced Protein 3TNFAIP3 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, The Fourth Affiliated Hospital of School of Medicine, & International School of Medicine, International Institutes of Medicine, Zhejiang University, Zhejiang, China.
  • Department of General Surgery, The Rizhao People's Hospital, Rizhao, China.
  • Central Laboratory, the Rizhao People's Hospital, Rizhao, China.

Förderung

  • Natural Science Foundation of Shandong Province

Zitieren

APA

Wu, Y., Qin, Z., & Wang, G. (2026). Downregulation of TNFAIP3 Associated With Poor Prognosis and Immune Response in Breast Cancer. Cancer Reports. https://doi.org/10.1002/cnr2.70443

Vancouver

Wu Y, Qin Z, Wang G. Downregulation of TNFAIP3 Associated With Poor Prognosis and Immune Response in Breast Cancer. Cancer Reports. 2026. doi:10.1002/cnr2.70443

BibTeX
@article{Wu2026,
  author = {Wu, Yeqin and Qin, Zhaoyang and Wang, Gangping},
  title = {Downregulation of TNFAIP3 Associated With Poor Prognosis and Immune Response in Breast Cancer},
  journal = {Cancer Reports},
  year = {2026},
  doi = {10.1002/cnr2.70443}
}
Kostenlos starten →